Further investigations of circulating antibodies in colon cancer patients: on the autoantigenicity of the carcinoembryonic antigen.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 5002518)

Published in Int J Cancer on September 15, 1971

Authors

E Collatz, S Von Kleist, P Burtin

Articles by these authors

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis (1985) 4.52

Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94

Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol (1980) 3.55

Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A (1972) 3.49

Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis (1988) 3.12

Primary structure of an aminoglycoside 6'-N-acetyltransferase AAC(6')-4, fused in vivo with the signal peptide of the Tn3-encoded beta-lactamase. J Bacteriol (1987) 3.05

Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg (2011) 2.91

Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256. Antimicrob Agents Chemother (1990) 2.70

Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother (1991) 2.68

SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60

Inducible carboxypeptidase activity in vancomycin-resistant enterococci. Antimicrob Agents Chemother (1992) 2.30

The H-NS protein is involved in the biogenesis of flagella in Escherichia coli. J Bacteriol (1994) 2.24

Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother (1990) 2.08

Comparison of vancomycin-inducible proteins from four strains of Enterococci. FEMS Microbiol Lett (1990) 2.01

Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst (1975) 1.91

Multidrug-resistant human and animal Salmonella typhimurium isolates in France belong predominantly to a DT104 clone with the chromosome- and integron-encoded beta-lactamase PSE-1. J Infect Dis (1999) 1.83

A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 1.77

Insertion of a novel DNA sequence, 1S1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol (1994) 1.74

Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob Agents Chemother (1993) 1.73

Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa. Microbiology (1998) 1.72

Isolation of a fetal antigen from human colonic tumors. Cancer Res (1969) 1.63

Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1. Biochim Biophys Acta (1999) 1.58

Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob Agents Chemother (1998) 1.56

Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem. J Mol Biol (2001) 1.54

Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid (1983) 1.52

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid. Antimicrob Agents Chemother (1991) 1.52

Analysis of peptidoglycan precursors in vancomycin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.50

Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance. J Infect Dis (1998) 1.48

Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet (1994) 1.48

Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation (1994) 1.47

Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol (1995) 1.44

Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature (1975) 1.41

Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: an immunofluorescence study. Int J Cancer (1982) 1.40

[MR-endoscopic US correlation for loco-regional staging of rectal carcinoma]. J Radiol (2007) 1.39

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39

In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol (Paris) (1983) 1.36

Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother (1997) 1.34

Immunohistological localization of carcinoembryonic antigen and nonspecific cross-reacting antigen in gastrointestinal normal and tumoral tissues. Cancer Res (1973) 1.30

Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother (1998) 1.28

Characterization of a second normal antigen that cross-reacts with CEA. J Immunol (1973) 1.27

An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa. Lab Invest (1976) 1.25

Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections. Cancer Res (1990) 1.24

Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother (2000) 1.20

Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 60 S ribosomal subunit proteins La, Lb, Lf, P1, P2, L13', L14, L18', L20, and L38. J Biol Chem (1978) 1.19

A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation. FEMS Microbiol Lett (1992) 1.18

Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy (2000) 1.17

A recent fixation of cfiA genes in a monophyletic cluster of Bacteroides fragilis is correlated with the presence of multiple insertion elements. J Bacteriol (1996) 1.17

Immunochemical study and cellular localization of human pepsinogens during ontogenesis and in gastric cancers. Lab Invest (1976) 1.15

The chromosomal 3',5"-aminoglycoside phosphotransferase in Streptococcus pneumoniae is closely related to its plasmid-coded homologs in Streptococcus faecalis and Staphylococcus aureus. J Bacteriol (1983) 1.13

Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae. J Gen Microbiol (1992) 1.12

Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-beta-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366. FEMS Microbiol Lett (1992) 1.11

[Isolation and identification of the autoantigen responsible for the formation of autoantibodies in patients with breast lesions (cancerous or noncancerous)]. Ann Inst Pasteur (Paris) (1968) 1.11

Enzyme electrophoresis, sero- and subtyping, and outer membrane protein characterization of two Neisseria meningitidis strains involved in laboratory-acquired infections. J Clin Microbiol (1994) 1.09

Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins. J Antimicrob Chemother (1984) 1.09

Risk of infectious diseases in children attending different types of day-care setting. Epicrèche Research Group. Respiration (1994) 1.09

Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins. FEMS Microbiol Lett (1995) 1.09

Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 40 S ribosomal subunit proteins Sa, Sc, S3a, S3b, S5', S9, S10, S11, S12, S14, S15, S15', S16, S17, S18, S19, S20, S21, S26, S27', and S29. J Biol Chem (1977) 1.09

Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. Antimicrob Agents Chemother (1994) 1.08

Loss of a normal colonic membrane antigen in human cancers of the colon. Cancer Res (1971) 1.08

Metastatic gastric cancer arising from breast carcinoma: endoscopic ultrasonographic aspects. Endoscopy (1998) 1.08

Antigens of gastric and intestinal mucous cells in human colonic tumours. Br J Cancer (1980) 1.07

Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi. Antimicrob Agents Chemother (1985) 1.07

On the specificity of autoantibodies present in colon cancer patients. Immunology (1966) 1.07

Genetic control of deficiencies in gamma-G subclasses observed among families with hypogammaglobulinaemia. Nature (1970) 1.07

Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur J Clin Microbiol Infect Dis (1991) 1.07

Antigenic sites in carcinoembryonic antigen. Cancer Res (1989) 1.06

[Formation of immunoglobulins in the fetus and young infant]. Ann Inst Pasteur (Paris) (1967) 1.06

[Cellular localization of an embryonic antigen in human colonic tumors]. Int J Cancer (1969) 1.06

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. J Clin Oncol (1998) 1.05

Abnormalities in synthesis of some subclasses of gamma-G in a family with two cases of ataxia telangiectasia. Vox Sang (1969) 1.04

Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness. Antimicrob Agents Chemother (1988) 1.03

Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile. Antimicrob Agents Chemother (1986) 1.03

Antigens common to human ovarian mucinous cyst fluid and gastric mucosa. Br J Cancer (1977) 1.01

Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc (1997) 1.01

[Study of beta-lactamase in Neisseria gonorrhoeae by a gel adaptation of the iodometric method]. Ann Biol Clin (Paris) (1983) 1.01

Video capsule endoscopy for investigation of obscure gastrointestinal bleeding: feasibility, results, and interobserver agreement. Endoscopy (2005) 0.99

[Isolation of the autoantigen responsible for the formation of autoantibodies in patients with gastric cancer]. Eur J Biochem (1967) 0.99

The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer (1990) 0.98

Isolation of a sulfated glycopeptidic antigen from human gastric tumors: its localization in normal and cancerous gastrointestinal tissues. Int J Cancer (1978) 0.98

Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis. J Bacteriol (2001) 0.97

Type of day-care setting and risk of repeated infections. Pediatrics (1994) 0.97

Serum alpha-1 foeto-protein (fetuin) in children with malignant ovarian or testicular teratomas. Preliminary results. Int J Cancer (1969) 0.97

Intestinal metaplasia and carcinomas of the human stomach: an immunohistological study. J Histochem Cytochem (1983) 0.96

Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child (2003) 0.96

First experience of topical SDZ ASM 981 in children with atopic dermatitis. Br J Dermatol (2001) 0.96

Long-range chromosomal mapping of the carcinoembryonic antigen (CEA) gene family cluster. Genomics (1992) 0.96

The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther (2007) 0.95

[Presence of a tissue protein, alpha 2H globulin, in the serum of patients with neoplastic diseases]. Int J Cancer (1968) 0.95

[Determination of immunoglobulins in the serum of cancer patients]. Ann Inst Pasteur (Paris) (1970) 0.95

Immunoglobulin-producing cells in human pericancerous lymph nodes. Cancer (1969) 0.95

Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis. Ther Drug Monit (1994) 0.94

A tumor-associated antigen in human nephroblastomas. Proc Natl Acad Sci U S A (1973) 0.94

[Autoantibodies in cancer patients]. Presse Med (1965) 0.94

Synthesis of human immunoglobulins in germinal centers of lymphoid organs. J Immunol (1967) 0.94

Toxicity and antioxidant activity in vitro and in vivo of two Fucus vesiculosus extracts. J Agric Food Chem (2008) 0.94

Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet (1996) 0.93

Comparative distribution of fibronectin and vitronectin in human breast and colon carcinomas. An immunofluorescence study. Am J Clin Pathol (1988) 0.93

[Comparative measurements of the lactotransferrin level in certain organs. Comparison between normal and fetal and cancerous tissues]. Pathol Biol (Paris) (1971) 0.93